Laurence A. Rubin
Algemeen Directeur bij Ellipsis Neurotherapeutics, Inc.
Profiel
Laurence A.
Rubin is currently the Chief Executive Officer at Ellipsis Neurotherapeutics, Inc. and also serves as a Director at Weizmann Canada.
Previously, he held the position of Chief Executive Officer at Ellipsis Biotherapeutics Corp.
and was a Professor at the University of Toronto.
Actieve functies van Laurence A. Rubin
| Bedrijven | Functie | Begin |
|---|---|---|
Ellipsis Neurotherapeutics, Inc.
 Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada. | Algemeen Directeur | 01-11-2004 |
Weizmann Canada
 Weizmann Canada Miscellaneous Commercial ServicesCommercial Services Weizmann Canada operates as a worldwide network of supporting organizations for the Weizmann Institute of Science. The company was founded in 1964 and is headquartered in Calgary, Canada. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Laurence A. Rubin
| Bedrijven | Functie | Einde |
|---|---|---|
Ellipsis Biotherapeutics Corp.
 Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | President | - |
| University of Toronto | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Ellipsis Neurotherapeutics, Inc.
Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada. | Health Technology |
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
Weizmann Canada
Weizmann Canada Miscellaneous Commercial ServicesCommercial Services Weizmann Canada operates as a worldwide network of supporting organizations for the Weizmann Institute of Science. The company was founded in 1964 and is headquartered in Calgary, Canada. | Commercial Services |
